Following The Money: Institution’s Growing Stake In Heron Therapeutics Inc (NASDAQ: HRTX)
Heron Therapeutics Inc (HRTX) concluded trading on Wednesday at a closing price of $1.86, with 10.42 million shares of worth about $19.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -25.90% during that period and on August 14, 2024 the price saw a […]
Heron Therapeutics Inc (NASDAQ: HRTX): Do Not Miss The Gain Train
Heron Therapeutics Inc (HRTX) concluded trading on Wednesday at a closing price of $2.00, with 9.04 million shares of worth about $18.07 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.79% during that period and on August 07, 2024 the price saw a […]
Assessing Whether Heron Therapeutics Inc (NASDAQ: HRTX) Is Over- Or Undervalued
Heron Therapeutics Inc (HRTX) concluded trading on Thursday at a closing price of $3.31, with 3.64 million shares of worth about $12.06 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 46.46% during that period and on July 11, 2024 the price saw a […]
Heron Therapeutics Inc (NASDAQ: HRTX) – Suitable For Long Term Buy?
Currently, there are 150.29M common shares owned by the public and among those 139.45M shares have been available to trade. The company’s stock has a 5-day price change of -10.16% and 7.45% over the past three months. HRTX shares are trading 61.18% year to date (YTD), with the 12-month market performance up to 136.21% higher. […]
Heron Therapeutics Inc (NASDAQ: HRTX) Stock In Prove Me State
Heron Therapeutics Inc (HRTX) concluded trading on Thursday at a closing price of $2.88, with 3.76 million shares of worth about $10.83 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 76.69% during that period and on Thursday the price saw a gain of […]
Reassessing The Changing Outlook For Heron Therapeutics Inc (HRTX)
Rubric Capital Management LP recently announced the acquisition of new stake in Heron Therapeutics Inc (NASDAQ:HRTX). The institutional investor has increased its shareholding in the Healthcare company by 127.35% to 26.71 million shares with purchase of 14.96 million shares. This fresh investment now brings its stake to 17.80% valued currently at $45.41 million. In addition, […]
Reassessing The Changing Outlook For Heron Therapeutics Inc (HRTX)
Rubric Capital Management LP recently announced the acquisition of new stake in Heron Therapeutics Inc (NASDAQ:HRTX). The institutional investor has increased its shareholding in the Healthcare company by 127.35% to 26.71 million shares with purchase of 14.96 million shares. This fresh investment now brings its stake to 17.80% valued currently at $32.86 million. In addition, […]
Technical Outlook And Game Plan For Heron Therapeutics Inc (NASDAQ: HRTX)
Heron Therapeutics Inc (HRTX) concluded trading on 12/28/23 at a closing price of $1.74, with 2.22 million shares of worth about $3.87 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 47.46% during that period and on Thursday the price saw a gain of […]
Stick With Heron Therapeutics Inc (HRTX). The Bull Are Alive And Well
Rubric Capital Management LP recently announced the acquisition of new stake in Heron Therapeutics Inc (NASDAQ:HRTX). The institutional investor has increased its shareholding in the Healthcare company by 127.35% to 26.71 million shares with purchase of 14.96 million shares. This fresh investment now brings its stake to 18.98% valued currently at $17.02 million. In addition, […]
Are Analysts Expecting A Better 2020 For Heron Therapeutics Inc (HRTX)?
Rubric Capital Management LP has recently announced that it has increased stake in Heron Therapeutics Inc (NASDAQ:HRTX) by 127.35%. After grabbing 26.71 million shares, the institutional investor is now in possession of 14.96 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 18.98% having worth around $27.51 million. […]
